INS and cancer: The finding that insulin-resistant patients show an elevated risk for several types of cancer further support a link between oxidative stress/chronic inflammation and tumorigenesis; insulin signaling (together with insulin-like growth factor (IGF), leptin and inflammatory cytokines) has mitogenic properties through activation of the PI3K/Akt/mammalian target of rapamycin (mTOR) pathway [119].